NDC 68083-515 – Octreotide Acetate
Octreotide Acetate 200 ug/mL · Injection, Solution · Intravenous, Subcutaneous
Product NDC68083-515
Product details
- Brand name
- Octreotide Acetate
- Generic name
- Octreotide Acetate
- Labeler
- Gland Pharma Limited
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA216807
- Marketed since
- June 13, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Somatostatin Analog
Active ingredients
- Octreotide Acetate 200 ug/mL
Uses, dosage, side effects and warnings for Octreotide Acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68083-515-01 | 1 VIAL in 1 CARTON (68083-515-01) / 5 mL in 1 VIAL | Jun 13, 2023 |
Other Octreotide Acetate products
- 68083-517 Octreotide Acetate 100 ug/mL · Injection, Solution · Gland Pharma Limited
- 68083-516 Octreotide Acetate 1000 ug/mL · Injection, Solution · Gland Pharma Limited
- 68083-560 Octreotide Acetate 500 ug/mL · Injection, Solution · Gland Pharma Limited
- 68462-896 Octreotide Acetate 100 ug/mL · Injection, Solution · GLENMARK PHARMACEUTICALS INC., USA
- 68462-897 Octreotide Acetate 500 ug/mL · Injection, Solution · GLENMARK PHARMACEUTICALS INC., USA
- 52958-046 Octreotide Acetate 100 ug/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 23155-685 Octreotide Acetate 200 ug/mL · Injection, Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-686 Octreotide Acetate 1000 ug/mL · Injection, Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-687 Octreotide Acetate 50 ug/mL · Injection, Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-688 Octreotide Acetate 100 ug/mL · Injection, Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-689 Octreotide Acetate 500 ug/mL · Injection, Solution · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 0641-6177 Octreotide Acetate 200 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.